3 ms·
Personally my money is on Favipiravir if I had to bet on which of the drugs in trial is mostly likely to turn out to be the best treatment but there are lots of
by Symmetry 7y ago
Personally my money is on Favipiravir if I had to bet on which of the drugs in trial is mostly likely to turn out to be the best treatment but there are lots of drugs in trial and we still need to know much more about all of them. In the meantime we're advancing our understanding of how to treat Covid-19 in other ways as well, such as finding out that proning patients can help in some circumstances.
- blhack 7y agoWhy is your money on that drug?
- christkv 7y agoIts a general anti-viral that targets RNA viruses in general so might be more effective.
- tyingq 7y agoDoes the "general" make it more promising than Remdesivir to you?
- Symmetry 7y agoThe preliminary clinical trail results seem to be the best so far, that's all. I haven't been following it that systematically and reporting is noisy so I'm not confident it'll be the best, it just seems to be in front at the moment.
- nradov 7y agoFavipiravir looks like a fairly simple molecule: C₅H₄FN₃O₂. Would any organic chemists care to comment on how difficult it would be to synthesize for large-scale medical grade production?